4-amino-3-(3,5-dimethylbenzofuran-2-yl)-2-(1-(4-hydroxybut-2-ynoyl)piperidin-4-yl)-2H-pyrazolo[3,4-d]pyridazin-7(6H)-one

ID: ALA5282211

Chembl Id: CHEMBL5282211

Max Phase: Preclinical

Molecular Formula: C24H24N6O4

Molecular Weight: 460.49

Names and Identifiers

Canonical SMILES:  Cc1ccc2oc(-c3c4c(N)n[nH]c(=O)c4nn3C3CCN(C(=O)C#CCO)CC3)c(C)c2c1

Standard InChI:  InChI=1S/C24H24N6O4/c1-13-5-6-17-16(12-13)14(2)22(34-17)21-19-20(24(33)27-26-23(19)25)28-30(21)15-7-9-29(10-8-15)18(32)4-3-11-31/h5-6,12,15,31H,7-11H2,1-2H3,(H2,25,26)(H,27,33)

Standard InChI Key:  NHVMUJXRECISKA-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5282211

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 460.49

Molecular Weight (Monoisotopic): 460.1859

AlogP: 1.89

#Rotatable Bonds: 2

Polar Surface Area: 143.27

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 10

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.75

CX Basic pKa: 0.88

CX LogP: 0.89

CX LogD: 0.87

Aromatic Rings: 4

Heavy Atoms: 34

QED Weighted: 0.39

Np Likeness Score: -0.51

References

1. Li C, Dai Y, Kong X, Wang B, Peng X, Wu H, Shen Y, Yang Y, Ji Y, Wang D, Li S, Li X, Shi Y, Geng M, Zheng M, Ai J, Liu H..  (2023)  Structural Optimization of Fibroblast Growth Factor Receptor Inhibitors for Treating Solid Tumors.,  66  (5): [PMID:36802596] [10.1021/acs.jmedchem.2c01507]

Source

Source(1):

• Scientific Literature